WEE1 and neoplasm: Synthesized as putative tyrosine kinase inhibitory compounds, the best working derivatives 1a, 1b and 1c were tested for their inhibitory activity against a panel of protein kinases consisting of 43 kinase targets that were preselected by tumor relevance and in silico target prediction (based on the lead compound 1c).